Pifetol 200 Tablet contains Pirfenidone 200 mg, an anti-fibrotic and anti-inflammatory agent used to manage idiopathic pulmonary fibrosis (IPF). It helps slow the progression of lung scarring, improving patients’ quality of life and pulmonary function.
Belonging to the pulmonology and anti-fibrotic segment, Pirfenidone is prescribed by pulmonologists for patients diagnosed with chronic fibrotic lung conditions. Its efficacy in reducing fibrosis makes it a critical therapy in specialized respiratory care centers.
The tablet works by modulating inflammatory mediators and fibroblast activity, which slows the development of fibrotic tissue in the lungs, supporting long-term respiratory health.
For PCD pharma franchise partners, wholesalers, exporters, and third-party manufacturers, Pifetol 200 Tablet provides a profitable B2B opportunity, catering to hospitals, clinics, and specialized pulmonology units across India.
Common side effects include nausea, vomiting, loss of appetite, rash, fatigue, and dizziness. Rare but serious side effects may include liver enzyme elevation, photosensitivity reactions, or severe allergic reactions. Seek medical attention if you experience jaundice, persistent nausea, or severe skin reactions.
Pifetol 200 Tablet is indicated for the treatment of idiopathic pulmonary fibrosis (IPF). It helps reduce the decline in lung capacity, improves exercise tolerance, and manages symptoms such as shortness of breath and chronic cough associated with lung scarring.
Take Pifetol 200 Tablet exactly as prescribed, preferably with food to reduce gastrointestinal discomfort. Avoid direct sunlight and use protective measures such as sunscreen. Inform your doctor if you have liver or kidney disorders, or are taking other medications that may affect liver function.
Store Pifetol 200 Tablet in a cool, dry place below 25°C, away from direct sunlight and moisture. Keep out of reach of children.